Historical record - last NADAC publication: 4/17/2024
Product Information
MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $41.9419 per ML under NDC 68180042101. Its NADAC has been published 5 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the MOXIFLOXACIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180042101
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
4/17/2024
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204079On Market Since
2/13/2020
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has been published 5 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.9419 per ML |
|---|---|
| All-time high | $41.9419 (May 15, 2024) |
| All-time low | $41.9419 (Apr 17, 2024) |
| Median price | $41.9419 |
| Average price | $41.9419 |
| Largest weekly change | 0.0% (Apr 24, 2024) |
| Weeks tracked | 5 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY), manufactured by Lupin Pharmaceuticals Inc., is $41.9419 per ML (NDC 68180042101), effective May 15, 2024.
How has the price of MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
Since Apr 17, 2024, the NADAC for MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) has ranged from a low of $41.9419 (Apr 17, 2024) to a high of $41.9419 (May 15, 2024), with a median of $41.9419 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MOXIFLOXACIN 0.5% EYE DROPS, is $1.6432 per ML — about 96% below MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY).
Who manufactures MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY)?
MOXIFLOXACIN 0.5% EYE DROP (VISCOUS) (TWICE DAILY) (NDC 68180042101) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification